StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -9390.8%, against -681.8% the year before. The highest annual figure on record is -23.6% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-9390.8%−8708.9
FY2024Dec 31, 2024-681.8%−542.8
FY2023Dec 31, 2023-139.1%+602.0
FY2022Dec 31, 2022-741.0%−209.3
FY2021Dec 31, 2021-531.7%−192.8
FY2020Dec 31, 2020-338.9%+189.7
FY2019Dec 31, 2019-528.6%−505.0
FY2018Dec 31, 2018-23.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-780.1%–
Q2 FY2023Jun 30, 2023-403.7%–
Q2 FY2022Jun 30, 2022-3868.0%–
Q2 FY2021Jun 30, 2021-454.0%–

More Addex Therapeutics figures

See a number that looks wrong?